Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a smart vest replace the stethoscope?

NCT ID NCT07464444

Diagnosis Sponsor: SonoHL Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a special vest called HALD that records heart and lung sounds. Researchers want to see if the recordings are as accurate as what a doctor hears with a stethoscope. About 200 adults with or without heart or lung conditions will wear the vest during a clinic visit. If it works, this could lead to remote check-ups where patients don't need to be in the doctor's office.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
HALD vest (cardiorespiratory recording device)
What this could lead to
If successful, this device could allow doctors to listen to heart and lung sounds remotely, making check-ups easier and more accessible.
What could go wrong
This is an early feasibility study with only 200 participants, so it may not prove the device works in all patients or settings. The recordings might not match in-person exams perfectly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Apr 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult participants presenting to pre-scheduled cardiology appointment, with suspected or history of known; valvular disease, heart failure, pericarditis, coronary artery disease, and other cardiovascular disease.

Ages

18 to 100 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Male or Female 2. Age ≥18 years old 3. Documented history of valvular heart disease, heart failure, pericarditis, coronary artery disease or other conditions with abnormal clinical cardiopulmonary assessment as well as control participants without abnormal physical examinations for a total of 60 participants. 4. Must have had an echocardiogram performed within 12 months of enrollment or have a scheduled echocardiogram appointment expected within the next 12 months. 5. Able and willing to provide written informed consent for study participation and able to comply with the required testing Exclusion Criteria: 1. \<18 years of age 2. Females pregnant, or lactating mothers 3. Participant with implantable electronic devices such as pacemakers or implantable cardioverter-defibrillator (ICD) 4. Participant has any kind of disorder that compromises his/her ability to give written informed consent and/or to comply with study evaluation

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Auscultation of heart and lungs are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

coronary artery disorder heart failure heart valve disorder pericarditis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Auscultation of heart and lungs

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Glen Centre Specilaized Medicine Clinic

    RECRUITING

    Montreal, Quebec, H4A 3T2, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.